Fedarko et al.,[37] |
Prostate, colon, breast, lung carcinomas |
In competitive ELISA assay, provided a high degree of sensitivity and specificity informative markers the detection of colon, breast, prostate & lung cancer |
Kim et al., [38] |
Epithelial ovarian cancer |
Plasma OPN were significantly higher in epithelial ovarian cancer (486.5ng/ml), benign lesion (254.4ng/ml) & compared with healthy controls (147.1ng/ml)- RT-PCR & ELISA |
Katakura et al.,[39] |
Oral cancer |
The elevated levels of interleukins-IL-1β, IL6, IL8 and OPN in the saliva of the oral cancer patient by ELISA method |
Thu Le Q et al.,[40] |
Head & neck Squamous cell carcinoma |
Significantly higher plasma OPN levels correlates relapse, survival rate and tumour recurrence |
Koopmans et al.,[41] |
Pancreatic adenocarcinoma |
Serum OPN levels were elevated in pancreatic adenocarcinoma as a diagnostic marker |
Bramwell et al.,[42] |
Metastatic breast cancer |
The increased level of OPN were strongly associated with poor survival and used in making treatment decisions |
Petrik et al.,[43] |
Head and Neck Squamous cell carcinoma |
Plasma OPN level was elevated in uncontrolled tumour (642ng/ml) correlates tumour control rate, event –free survival and post relapse survival |
Cho et al., [44] |
Cervical cancer |
plasma OPN levels are potentially useful as diagnostic and prognostic biomarker for cervical cancer |
Zhou et al.,[45] |
Oral Lichen Planus-premalignant lesion |
In ELISA, The serum concentration of OPN and TNF- α were significantly higher in OLP patient than the normal control |